Comparative study on the effects of kynurenic acid and glucosamine-kynurenic acid
Kynurenic acid (KYNA) is the only known endogenous N-methyl-D-aspartate (NMDA) receptor inhibitor and might therefore come into consideration as a therapeutic agent in certain neurobiological disorders. However, its use as a neuroprotective compound is practically excluded because KYNA does not read...
Elmentve itt :
Szerzők: |
Füvesi Judit Somlai Csaba Németh Hajnalka Varga Hedvig Kis Zsolt Farkas Tamás Károly Norbert Dobszay Márton Penke Zsuzsa Penke Botond Vécsei László Toldi József |
---|---|
Dokumentumtípus: | Cikk |
Megjelent: |
2004
|
Sorozat: | PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
77 No. 1 |
doi: | 10.1016/j.pbb.2003.10.001 |
mtmt: | 105674 |
Online Access: | http://publicatio.bibl.u-szeged.hu/10111 |
Hasonló tételek
-
Systemically administered glucosamine-kynurenic acid, but not pure kynurenic acid, is effective in decreasing the evoked activity in area CA1 of the rat hippocampus
Szerző: Robotka Hermina, et al.
Megjelent: (2005) -
Protective effects of glucosamine-kynurenic acid after compression-induced spinal cord injury in the rat
Szerző: Korimova Andrea, et al.
Megjelent: (2012) -
The Janus-face kynurenic acid
Szerző: Rózsa Éva, et al.
Megjelent: (2008) -
Memantine and kynurenic acid Current neuropharmacological aspects /
Szerző: Majláth Zsófia, et al.
Megjelent: (2016) -
A novel kynurenic acid analogue a comparison with kynurenic acid. An in vitro electrophysiological study /
Szerző: Marosi Máté Gábor, et al.
Megjelent: (2010)